Janus Henderson Group PLC Immunity Bio, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 118,739 shares of IBRX stock, worth $280,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,739
Previous 59,840
98.43%
Holding current value
$280,224
Previous $180,000
73.89%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IBRX
# of Institutions
281Shares Held
121MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$51.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$27 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$20.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$18.3 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$18.2 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $945M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...